STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2023

STOCK-BASED COMPENSATION [Abstract]

Information Regarding Equity Incentive Plan

The table below includes issuances of restricted stock awards and units under the 2020 Plan and unvested equity interests of MOR which were converted into restricted Company common stock.

	Number of Restricted Shares and Units			Weighted Average Grant Date Fair Value Per Share
Unvested at January 1, 2022		1,146,131		$	1.28
Issued		—			11.71
Vested		(474,768	)		0.03
Canceled		(120,105	)		12.18
Unvested at December 31, 2022		551,258			3.28
Issued		570,000			3.79
Vested		(189,885	)		4.39
Canceled		(20,653	)		0.16
Unvested at March 31, 2023		910,720		$	5.78

Fair Value of Stock Option Assumptions

The assumptions used to calculate the grant date fair value of the options outstanding at March 31, 2023 and December 31, 2022 are as follows:

	March 31,		December 31,
	2023		2022
Exercise Price	$	2.00 to $51.80	$	2.00 to $51.80
Fair value of Company common stock	$	2.98 to $15.61	$	2.98 to $15.61
Dividend yield		0%		0%
Expected volatility	79% to 188%		83% to 188%
Risk Free interest rate	0.27% to 4.52%		0.27% to 4.52%
Expected life (years) remaining	0.01 to 9.62		0.01 to 9.62

Stock Option Activity

Stock option activity for the three months ended March 31, 2023 and 2022 is as follows:

	Shares Underlying Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)
Outstanding at January 1, 2022		4,046,973		$	14.25		8.75
Granted		1,203,250		$	4.02		9.14
Exercised		(33,334	)	$	2.47		2.55
Forfeited and expired		(1,233,081	)	$	13.87		8.12
Outstanding at December 31, 2022		3,983,808		$	10.53		8.23
Granted		1,097,500		$	3.79		8.70
Exercised		(2,452	)	$	8.09		8.09
Forfeited and expired		(444,554	)	$	11.09		8.13
Outstanding at March 31, 2023		4,634,302		$	8.89		8.36
Vested options at March 31, 2023		2,076,200		$	12.59		6.94

Stock Compensation Expense

Stock compensation expense for the three months ended March 31, 2023 and 2022 is as follows:

	For the Three Months Ended March 31,
	2023			2022
Services	$	37,926		$	19,629
Research and development		38,192			47,441
Sales and marketing		54,002			51,821
General and administrative		1,348,281			2,078,044
Separation expenses		349,832			5,417,043
Subtotal		1,828,233			7,613,978
Discontinued operations		(247,308	)		290,606
Total	$	1,580,925		$	7,904,584